BLADE Entertainment CO.,LTD. Stock

Equities

A044480

KR7044480002

Pharmaceuticals

End-of-day quote Korea S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
944 KRW -1.15% Intraday chart for BLADE Entertainment CO.,LTD. +1.83% -16.46%
Sales 2022 78.06B 56.75M Sales 2023 96.99B 70.51M Capitalization 38.52B 28.01M
Net income 2022 -18.45B -13.41M Net income 2023 -13.81B -10.04M EV / Sales 2022 0.58 x
Net cash position 2022 2.91B 2.11M Net Debt 2023 28.72B 20.88M EV / Sales 2023 0.69 x
P/E ratio 2022
-2.62 x
P/E ratio 2023
-2.72 x
Employees 91
Yield 2022 *
-
Yield 2023
-
Free-Float 69.23%
More Fundamentals * Assessed data
Dynamic Chart
BLADE Entertainment CO.,LTD. announced that it has received KRW 1.999999596 billion in funding CI
Blade Entertainment to Raise 2 Billion Won From Shares Issuance; Shares Climb 4% MT
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 1.999999596 billion in funding CI
BLADE Entertainment CO.,LTD. announced that it expects to receive KRW 10 billion in funding CI
Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 9.02379645 billion in funding from Blueberry NFT CO.,LTD. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6 billion in funding CI
Blueberry NFT CO.,LTD. announced that it has received KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 5 billion in funding from Metaplex Co., Ltd. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Blueberry NFT CO.,LTD. announced that it expects to receive KRW 6.999999435 billion in funding from Jang San Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it has received KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
Kyung Nam Pharm HealthCare Co.,Ltd. announced that it expects to receive KRW 3.999997925 billion in funding from Blueberry NFT CO.,LTD., Kyung Nam Pharm Co.,Ltd. CI
Blueberry NFT CO.,LTD. announced that it has received KRW 9.999999625 billion in funding from Jangsan Co., Ltd. CI
Kyung Nam Biopharma CO.,LTD. announced that it expects to receive KRW 9.999999625 billion in funding from Jangsan Co., Ltd. CI
More news
1 day-1.15%
1 week+1.83%
Current month+7.27%
1 month+10.67%
3 months-11.78%
6 months-14.03%
Current year-16.46%
More quotes
1 week
920.00
Extreme 920
1 030.00
1 month
847.00
Extreme 847
1 097.00
Current year
847.00
Extreme 847
1 219.00
1 year
847.00
Extreme 847
1 551.00
3 years
847.00
Extreme 847
4 945.00
5 years
847.00
Extreme 847
9 930.00
10 years
847.00
Extreme 847
19 650.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 -
Chief Executive Officer 52 -
Comptroller/Controller/Auditor 52 -
Members of the board TitleAgeSince
Chief Executive Officer 52 -
Chief Executive Officer 46 -
Director/Board Member 65 -
More insiders
Date Price Change Volume
24-04-25 944 -1.15% 27,600
24-04-24 955 -0.73% 83,794
24-04-23 962 -1.33% 75,268
24-04-22 975 +0.93% 287,627
24-04-19 966 +4.21% 197,295

End-of-day quote Korea S.E., April 24, 2024

More quotes
Blade Entertainment Co Ltd, formerly Blueberry NFT Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the manufacture and sale of medicines such as vitamins, placentas and health foods. The Company is also engaged in the manufacture and sale of rubber products such as condoms and gloves, as well as masks such as KF-94. In addition, the Company is engaged in the development and provision of software such as non-fungible tokens (NFTs).
More about the company
  1. Stock Market
  2. Equities
  3. A044480 Stock